These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8749668)

  • 1. The molecular basis of pneumococcal infection: a hypothesis.
    Cundell D; Masure HR; Tuomanen EI
    Clin Infect Dis; 1995 Dec; 21 Suppl 3():S204-11. PubMed ID: 8749668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells.
    Cundell DR; Gerard C; Idanpaan-Heikkila I; Tuomanen EI; Gerard NP
    Adv Exp Med Biol; 1996; 416():89-94. PubMed ID: 9131132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular mechanisms of pneumococcal meningitis.
    Tuomanen EI
    Ann N Y Acad Sci; 1996 Oct; 797():42-52. PubMed ID: 8993350
    [No Abstract]   [Full Text] [Related]  

  • 4. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media.
    Keller LE; Bradshaw JL; Pipkins H; McDaniel LS
    Front Cell Infect Microbiol; 2016; 6():55. PubMed ID: 27242973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor.
    Cundell DR; Gerard NP; Gerard C; Idanpaan-Heikkila I; Tuomanen EI
    Nature; 1995 Oct; 377(6548):435-8. PubMed ID: 7566121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signalling or binding: the role of the platelet-activating factor receptor in invasive pneumococcal disease.
    Iovino F; Brouwer MC; van de Beek D; Molema G; Bijlsma JJ
    Cell Microbiol; 2013 Jun; 15(6):870-81. PubMed ID: 23444839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal wall teichoic acid is required for the pathogenesis of Streptococcus pneumoniae in murine models.
    Xu H; Wang L; Huang J; Zhang Y; Ma F; Wang J; Xu W; Zhang X; Yin Y; Wu K
    J Microbiol; 2015 Feb; 53(2):147-54. PubMed ID: 25626371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza.
    McCullers JA; Iverson AR; McKeon R; Murray PJ
    Scand J Infect Dis; 2008; 40(1):11-7. PubMed ID: 17852951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation.
    Pracht D; Elm C; Gerber J; Bergmann S; Rohde M; Seiler M; Kim KS; Jenkinson HF; Nau R; Hammerschmidt S
    Infect Immun; 2005 May; 73(5):2680-9. PubMed ID: 15845469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae.
    Cabellos C; MacIntyre DE; Forrest M; Burroughs M; Prasad S; Tuomanen E
    J Clin Invest; 1992 Aug; 90(2):612-8. PubMed ID: 1322943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between colonial morphology and adherence of Streptococcus pneumoniae.
    Cundell DR; Weiser JN; Shen J; Young A; Tuomanen EI
    Infect Immun; 1995 Mar; 63(3):757-61. PubMed ID: 7868244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Otitis media: the chinchilla model.
    Giebink GS
    Microb Drug Resist; 1999; 5(1):57-72. PubMed ID: 10332723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide methionine sulfoxide reductase contributes to the maintenance of adhesins in three major pathogens.
    Wizemann TM; Moskovitz J; Pearce BJ; Cundell D; Arvidson CG; So M; Weissbach H; Brot N; Masure HR
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7985-90. PubMed ID: 8755589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology.
    Fillon S; Soulis K; Rajasekaran S; Benedict-Hamilton H; Radin JN; Orihuela CJ; El Kasmi KC; Murti G; Kaushal D; Gaber MW; Weber JR; Murray PJ; Tuomanen EI
    J Immunol; 2006 Nov; 177(9):6182-91. PubMed ID: 17056547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal infections in an era of multiple antibiotic resistance.
    Gray BM
    Adv Pediatr Infect Dis; 1996; 11():55-99. PubMed ID: 8718460
    [No Abstract]   [Full Text] [Related]  

  • 16. Drastic reduction in the virulence of Streptococcus pneumoniae expressing type 2 capsular polysaccharide but lacking choline residues in the cell wall.
    Kharat AS; Tomasz A
    Mol Microbiol; 2006 Apr; 60(1):93-107. PubMed ID: 16556223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.
    McCullers JA; Rehg JE
    J Infect Dis; 2002 Aug; 186(3):341-50. PubMed ID: 12134230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of pneumococcal phase variation, host and pressure/gas composition: virulence expression of NanA, HylA, PspA and CbpA in simulated otitis media.
    Li-Korotky HS; Lo CY; Banks JM
    Microb Pathog; 2010 Oct; 49(4):204-10. PubMed ID: 20576489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotyping of Brunei pneumococcal clinical strains and the investigation of their capability to adhere and invade a brain endothelium model.
    Rahman NA; Sharudin A; Diah S; Muharram SH
    Microb Pathog; 2017 Sep; 110():352-358. PubMed ID: 28711510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal virulence factors: structure and function.
    Jedrzejas MJ
    Microbiol Mol Biol Rev; 2001 Jun; 65(2):187-207 ; first page, table of contents. PubMed ID: 11381099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.